Notice of Meeting

CourtSubstance Abuse And Mental Health Services Administration
Citation87 FR 9631
Published date22 February 2022
Record Number2022-03616
Federal Register, Volume 87 Issue 35 (Tuesday, February 22, 2022)
[Federal Register Volume 87, Number 35 (Tuesday, February 22, 2022)]
                [Notices]
                [Pages 9631-9632]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2022-03616]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                Substance Abuse and Mental Health Services Administration
                Notice of Meeting
                 Pursuant to Public Law 92-463, notice is hereby given that the
                Substance Abuse and Mental Health Services Administration's (SAMHSA)
                Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory
                Board (DTAB) will convene via web conference on March 9, 2022, from
                10:00 a.m. ET to 1:00 p.m. ET.
                 The board will meet in open-session on March 9, 2022, from 10:00
                a.m. ET to 1:00 p.m. ET, to discuss the Mandatory Guidelines for
                Federal Workplace Drug Testing Programs with updates from the
                Department of Transportation, the Nuclear Regulatory Commission and the
                Food and Drug
                [[Page 9632]]
                Administration. Other discussion topics include a presentation on the
                Drug-Free Workplace Program Summit meeting scheduled for May, 2022,
                NLCP drug testing results, and synthetic urines and adulteration.
                 Meeting registration information can be completed at http://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call
                information will be sent after completing registration. Meeting
                information and a roster of DTAB members may be obtained by accessing
                the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Designated Federal
                Officer, Lisa S. Davis, M.S.
                 Committee Name: Substance Abuse and Mental Health Services
                Administration, Center for Substance Abuse Prevention, Drug Testing
                Advisory Board.
                 Dates/Time/Type: March 9, 2022, from 10:00 a.m. to 1:00 p.m.: OPEN.
                 Place: Substance Abuse and Mental Health Services Administration,
                5600 Fishers Lane, Rockville, MD 20857.
                 Contact: Lisa S. Davis, M.S., Social Science Analyst, Center for
                Substance Abuse Prevention, 5600 Fishers Lane, Rockville, Maryland
                20857, Telephone: (240) 276-1440, Email: [email protected].
                Anastasia Marie Donovan,
                Public Health Advisor, Division of Workplace Programs.
                [FR Doc. 2022-03616 Filed 2-18-22; 8:45 am]
                BILLING CODE 4162-20-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT